دورية أكاديمية

USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer

التفاصيل البيبلوغرافية
العنوان: USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer
Alternate Title: USH2A 突变和其他关键驱动基因突变亚型与免疫检查点抑制剂在肺癌患者中临床联系的关联研究
المؤلفون: Yang, DexinAff1, Aff4, Aff5, Feng, Yuqin, Lu, Haohua, Chen, Kelie, Xu, Jinming, Li, Peiwei, Wang, Tianru, Xia, DajingAff1, IDjzusB2200292_cor8, Wu, YihuaAff1, Aff3, IDjzusB2200292_cor9
المصدر: Journal of Zhejiang University-SCIENCE B: Biomedicine & Biotechnology. 24(2):143-156
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:16731581
18621783
DOI:10.1631/jzus.b2200292